METHOD FOR PRODUCTION OF GENETICALLY MODIFIED ORGANISM FOR SCREENING OF BIOLOGICALLY ACTIVE SUBSTANCES Russian patent published in 2009 - IPC C12N1/00 C12N15/00 C12Q1/68 C12N1/02 

Abstract RU 2376364 C2

FIELD: medicine.

SUBSTANCE: genetically modified cell of yeast is produced either by introduction of an alien gene, or by variation in expression of its own gene. To compensate effect of these genes in cell, expression of certain genes is varied in ascending (up-regulation) or descending (down-regulation) manner. Using micromatrices (microarrays) of DNA, they identify compensatory expressing genes. Compensatory genes are affected, which results in reduction or cessation of expression of up-regulated genes or improved expression of down-regulated genes. As a result, a phenotype occurs in cell, which expresses as inhibitor of its growth.

EFFECT: invention makes it possible to produce organism for screening of biologically active substances, which affect genes, expression variation of which does not show in phenotype manner.

9 cl, 1 dwg, 4 tbl, 2 ex

Similar patents RU2376364C2

Title Year Author Number
METHOD OF AGENT IDENTIFICATION 2003
  • Grattser Zabine
  • De Khop Melts'E
  • Maj Bernkhard
RU2325652C2
METHOD OF ASSAY OF ABILITY OF TESTING SAMPLE TO EFFECT ON INTERACTION OF BINDING FIRST AND SECOND PEPTIDE IN PAIR OF PEPTIDE BINDING (VARIANTS) AND METHOD OF ASSAY OF BINDING ORDER OF TESTING SAMPLE WITH PEPTIDE IN PAIR OF PEPTIDE BINDING (VARIANTS) 1995
  • Jang Kehslin Ehjch
  • Ozenberger Brehdli Ehj
RU2208646C2
METHOD FOR IDENTIFICATION AND/OR VERIFICATION OF INHIBITORS OF RECEPTOR TYROSINE KINASES 2003
  • Gunde Tea
  • Berset Katrin
  • Barberi Olsajd
RU2366716C2
METHOD FOR PREPARING PROTEINS IN TRANSFORMED YEAST CELLS 1999
  • K'Ell'Sen Tomas
  • Vad Knud
RU2238323C2
DOUBLE HYBRID SYSTEM BASED ON GENE SILENCING BY TRANSCRIPTIONAL INTERFERENCE 2005
  • Furn'E Alen
  • Berens Ral'F
  • Band'Era Sil'Vio
RU2403287C2
MINUS-CHAIN-CONTAINING ATTENUATED VIRUSES WITH CHANGED ANTAGONISTIC ACTIVITY AS REGARDS FOR INTERFERON FOR APPLYING AS VACCINES AND PHARMACEUTICAL SUBSTANCES 1999
  • Palez Piter
  • Garsia-Sastre Adol'Fo
  • Master Tomas
RU2236252C2
FUNCTIONAL IMPROVEMENT OF MICROORGANISMS TO MINIMIZE ACRYLAMIDE PRODUCTS 2011
  • Chkhan Alin
  • Khasnik Dzhon Ivan
RU2603061C2
HEAT-INDUCED PROMOTER AND ITS USING 2000
  • Romano Ivano
  • Gellissen Gerd
  • De Virdzhilio Klaudio
RU2230786C2
METHOD FOR INCORPORATION OF DSRNA OR DNA ABLE FOR PRODUCING DSRNA (VARIANTS) INTO C. ELEGANS, METHOD FOR NEGATIVE REGULATION OF EXPRESSION OF INTERSETING GENE IN C. ELEGANS (VARIANTS) 1999
  • Platink Gert
  • Platteu Khrist
  • Mort'E Katrin
  • Bogart Tirri
RU2240349C2
HOST CELLS AND WAYS TO USE 2014
  • Tszin Yunkhvan
  • Chzhu Yuan
RU2663587C2

RU 2 376 364 C2

Authors

Klebl' Bert

Shtadler Anja

Zellner Rozemari

Leberer Ehkkekhard

Nitshe Al'Mut

Dates

2009-12-20Published

2003-11-18Filed